Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEROID-LITE: Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for TNBC
NCT07914309Phase 2Not yet recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone, olanzapine in triple-negative breast cancer (TNBC), sponsored by Washington University School of Medicine. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dexamethasoneolanzapine
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT07914309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914309.